BIOCON | PROCTER & GAMBLE HEALTH | BIOCON / PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 22.9 | 34.6 | 66.1% | View Chart |
P/BV | x | 2.1 | 10.6 | 19.9% | View Chart |
Dividend Yield | % | 0.5 | 2.0 | 24.3% |
BIOCON PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BIOCON Mar-23 |
PROCTER & GAMBLE HEALTH Jun-23 |
BIOCON / PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 388 | 5,366 | 7.2% | |
Low | Rs | 192 | 3,883 | 4.9% | |
Sales per share (Unadj.) | Rs | 93.1 | 740.7 | 12.6% | |
Earnings per share (Unadj.) | Rs | 5.4 | 138.2 | 3.9% | |
Cash flow per share (Unadj.) | Rs | 14.6 | 155.2 | 9.4% | |
Dividends per share (Unadj.) | Rs | 1.50 | 95.00 | 1.6% | |
Avg Dividend yield | % | 0.5 | 2.1 | 25.2% | |
Book value per share (Unadj.) | Rs | 146.5 | 447.6 | 32.7% | |
Shares outstanding (eoy) | m | 1,200.60 | 16.60 | 7,232.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.1 | 6.2 | 49.9% | |
Avg P/E ratio | x | 54.1 | 33.5 | 161.7% | |
P/CF ratio (eoy) | x | 19.8 | 29.8 | 66.5% | |
Price / Book Value ratio | x | 2.0 | 10.3 | 19.1% | |
Dividend payout | % | 28.0 | 68.7 | 40.8% | |
Avg Mkt Cap | Rs m | 347,814 | 76,761 | 453.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 21,810 | 2,062 | 1,057.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 111,742 | 12,296 | 908.8% | |
Other income | Rs m | 7,681 | 184 | 4,176.7% | |
Total revenues | Rs m | 119,423 | 12,480 | 956.9% | |
Gross profit | Rs m | 16,611 | 3,247 | 511.6% | |
Depreciation | Rs m | 11,131 | 281 | 3,961.2% | |
Interest | Rs m | 4,190 | 8 | 54,415.6% | |
Profit before tax | Rs m | 8,971 | 3,142 | 285.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2,541 | 847 | 299.9% | |
Profit after tax | Rs m | 6,430 | 2,295 | 280.2% | |
Gross profit margin | % | 14.9 | 26.4 | 56.3% | |
Effective tax rate | % | 28.3 | 27.0 | 105.0% | |
Net profit margin | % | 5.8 | 18.7 | 30.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 123,340 | 11,713 | 1,053.0% | |
Current liabilities | Rs m | 85,107 | 6,791 | 1,253.3% | |
Net working cap to sales | % | 34.2 | 40.0 | 85.5% | |
Current ratio | x | 1.4 | 1.7 | 84.0% | |
Inventory Days | Days | 129 | 263 | 49.1% | |
Debtors Days | Days | 117 | 343 | 34.0% | |
Net fixed assets | Rs m | 394,078 | 10,617 | 3,711.8% | |
Share capital | Rs m | 6,003 | 166 | 3,616.3% | |
"Free" reserves | Rs m | 169,926 | 7,265 | 2,339.1% | |
Net worth | Rs m | 175,929 | 7,431 | 2,367.7% | |
Long term debt | Rs m | 152,905 | 0 | - | |
Total assets | Rs m | 517,418 | 22,330 | 2,317.2% | |
Interest coverage | x | 3.1 | 409.1 | 0.8% | |
Debt to equity ratio | x | 0.9 | 0 | - | |
Sales to assets ratio | x | 0.2 | 0.6 | 39.2% | |
Return on assets | % | 2.1 | 10.3 | 19.9% | |
Return on equity | % | 3.7 | 30.9 | 11.8% | |
Return on capital | % | 4.0 | 42.4 | 9.4% | |
Exports to sales | % | 3.1 | 0 | - | |
Imports to sales | % | 6.0 | 13.1 | 45.6% | |
Exports (fob) | Rs m | 3,467 | NA | - | |
Imports (cif) | Rs m | 6,654 | 1,605 | 414.5% | |
Fx inflow | Rs m | 3,467 | 1,465 | 236.6% | |
Fx outflow | Rs m | 6,654 | 1,605 | 414.5% | |
Net fx | Rs m | -3,187 | -140 | 2,273.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 18,525 | 2,360 | 785.0% | |
From Investments | Rs m | -142,818 | -215 | 66,427.0% | |
From Financial Activity | Rs m | 130,487 | -985 | -13,251.4% | |
Net Cashflow | Rs m | 6,411 | 1,160 | 552.5% |
Indian Promoters | % | 40.4 | 0.0 | - | |
Foreign collaborators | % | 20.3 | 51.8 | 39.1% | |
Indian inst/Mut Fund | % | 19.3 | 20.0 | 96.7% | |
FIIs | % | 5.6 | 6.2 | 90.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 39.4 | 48.2 | 81.7% | |
Shareholders | 470,261 | 56,778 | 828.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BIOCON With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Biocon | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 5.59% | -0.43% | 0.45% |
1-Month | 18.99% | -1.15% | 2.55% |
1-Year | 33.04% | 0.73% | 56.14% |
3-Year CAGR | -8.10% | -8.76% | 15.22% |
5-Year CAGR | -0.19% | 4.97% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Biocon share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of Biocon hold a 60.6% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of Biocon, and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.